Label: SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL SCALP BUTTER CREAM- sulfur, salicylic acid ointment

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 21, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts

  • Active Ingredient

    Sulfur, 5%

    Salicylic Acid, 3%

    Purpose

    Antidandruff

  • Use

    • relieves the itching and scaling associated with dandruff
  • Warnings

    For external use only

    When using this product

    avoid contact with eyes. If contact occurs rinse eyes thoroughly with water.

    Stop use and consult a doctor if

    • condition worsens or does not improve after regular use as directed.
    • HAIR IS FLAMMABLE. Flammability is increased by product build-up. Keep hair away from sparks, flame, extreme heat or lit tobacco.

    Keep out of reach of children.

    If swallowed, get medical help or call a Poison Control Center right away.

  • Directions

    • Apply a small amount to the scalp one to four times daily or as directed by a doctor.
  • Inactive Ingredients

    Petrolatum, Mineral Oil, Tribehenin, Arachidyl Propionate, Polysorbate 20, Fragrance

  • Package Labeling:

    3

  • INGREDIENTS AND APPEARANCE
    SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL SCALP BUTTER CREAM 
    sulfur, salicylic acid ointment
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:12022-035
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SULFUR (UNII: 70FD1KFU70) (SULFUR - UNII:70FD1KFU70) SULFUR50 mg  in 1 g
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID30 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    PETROLATUM (UNII: 4T6H12BN9U)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    TRIBEHENIN (UNII: 8OC9U7TQZ0)  
    ARACHIDYL PROPIONATE (UNII: QV5DAH3MSB)  
    POLYSORBATE 20 (UNII: 7T1F30V5YH)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:12022-035-0099 g in 1 JAR; Type 0: Not a Combination Product01/01/2020
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM03201/01/2020
    Labeler - J. Strickland and Co. (007023112)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!